Takeda Withdraws US Application for Dengue Vaccine Candidate

Following discussions with the FDA, Takeda has decided to withdraw the Biologics License Application for its investigational dengue vaccine, TAK-003.

Related Keywords

United Kingdom ,Indonesia ,Brazil ,Argentina ,Thailand ,Gary Dubin ,Drug Administration ,Biologics License Application ,Vaccines Business ,